Ticker Details
Tevogen Bio Holdings Inc. Common Stock
IPO Date:	February 15, 2024
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$56.43M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.10 | 5.65%
Avg Daily Range (30 D):	$0.01 | 4.43%
Avg Daily Range (90 D):	$0.02 | 4.60%

Institutional Daily Volume
Avg Daily Volume:	2.84M
Avg Daily Volume (30 D):	.65M
Avg Daily Volume (90 D):	.69M

Trade Size
Avg Trade Size (Sh.):	366
Avg Trade Size (Sh.) (30 D):	490
Avg Trade Size (Sh.) (90 D):	423

Institutional Trades
Total Institutional Trades:	4
Avg Institutional Trade:	$.83M
Avg Institutional Trade (30 D):	$.98M
Avg Institutional Trade (90 D):	$.98M
Avg Institutional Trade Volume:	.68M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$.86M
Avg Closing Trade (30 D):	$.98M
Avg Closing Trade (90 D):	$.98M
Avg Closing Volume:	913.51K

News

Jan 30, 2026 @ 8:00 PM Tevogen Board to Evaluate Potential One-Time Speci... Source: Na

Jan 29, 2026 @ 7:45 PM Tevogen to Align Long-Term Stock-Based Incentive P... Source: Na

Dec 8, 2025 @ 7:50 PM Tevogen Recognized on 2025 NJBIZ Power List Amid G... Source: Tevogen Bio Communications

Nov 3, 2025 @ 7:45 PM Tevogen Clarifies Reported Financials, Highlightin... Source: Kirti Desai (Cfo)

Oct 15, 2025 @ 7:50 PM Tevogen Updates on TVGN 489 Following Growing Long... Source: Dr. Ryan Saadi

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-.03	$-.03	$-.07
Diluted EPS	$-.03	$-.03	$-.07
Revenue	$-.06M	$-.04M	$M
Gross Profit
Net Income / Loss	$-5.73M	$-5.5M	$-10.37M
Operating Income / Loss	$-5.73M	$-5.44M	$-10.36M
Cost of Revenue
Net Cash Flow	$M	$M	$M
PE Ratio